Department of Anatomy, China Medical University, Shenyang, China.
J Voice. 2012 Nov;26(6):815.e17-23. doi: 10.1016/j.jvoice.2012.04.007. Epub 2012 Aug 24.
OBJECTIVES/HYPOTHESIS: Laryngeal edema is a common clinical condition. However, the underlying molecular mechanisms remain elusive. Aquaporins (AQPs) are small integral plasma membrane proteins that transport water across the plasma membrane. In this study, we explore the relationship between inflammatory laryngeal edema induced by compound 48/80 and the expression of AQPs.
Prospective, controlled, experimental animal study.
Healthy adult male SD rats were injected with either sterile water, compound 48/80 (2 mg/kg), or compound 48/80 plus dexamethasone (3 mg/kg) via the tail vein. The larynxes were harvested 10, 30 minutes, and 1 hour after the injection for the measurement of sublaryngeal water content and histological and molecular evaluations.
Ten and 30 minutes after the compound 48/80 injection compared with the sterile water injection control groups, the water content in subglottic larynx increased significantly and the tissues were markedly swollen accompanied with inflammatory cell infiltration. AQP1 and AQP5 mRNA decreased significantly. One hour after the compound 48/80 injection, the edema was diminished, but the inflammatory cell infiltration remained. AQP1 was elevated but AQP5 was still lower than controls. Dexamethasone did not significantly reduce laryngeal edema, but significantly reduced inflammatory cells infiltration induced by compound 48/80 injection. Dexamethasone increased the AQP5 level but not AQP1.
AQP1 and AQP5 might play key roles in inflammatory subglottic edema caused by compound 48/80 in rats. AQP1 and AQP5 might be useful molecular targets of clinical treatment of inflammatory laryngeal edema.
目的/假说:喉水肿是一种常见的临床病症。然而,其潜在的分子机制尚不清楚。水通道蛋白(AQP)是一种小的、完整的质膜蛋白,可将水穿过质膜运输。在这项研究中,我们探讨了由 48/80 复合化合物引起的炎症性喉水肿与 AQP 表达之间的关系。
前瞻性、对照、实验动物研究。
通过尾静脉向健康成年雄性 SD 大鼠注射无菌水、48/80 化合物(2mg/kg)或 48/80 化合物加地塞米松(3mg/kg)。注射后 10、30 分钟和 1 小时采集喉组织,用于测量下喉部水含量以及组织学和分子评估。
与无菌水注射对照组相比,48/80 化合物注射后 10 和 30 分钟,会显著增加会厌下喉的水含量,组织明显肿胀并伴有炎症细胞浸润。AQP1 和 AQP5 的 mRNA 水平显著降低。48/80 化合物注射后 1 小时,水肿减轻,但炎症细胞浸润仍然存在。AQP1 升高,但 AQP5 仍低于对照组。地塞米松虽不能显著减轻喉水肿,但能显著减少 48/80 化合物引起的炎症细胞浸润。地塞米松增加了 AQP5 的水平,但没有增加 AQP1。
AQP1 和 AQP5 可能在大鼠 48/80 复合化合物引起的炎症性会厌下水肿中发挥关键作用。AQP1 和 AQP5 可能是治疗炎症性喉水肿的临床治疗的有用分子靶点。